| 000 | 01787 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516122744.0 | ||
| 264 | 0 | _c20130815 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1525-6049 | ||
| 024 | 7 |
_a10.3109/0886022X.2012.745785 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShah, Hitesh H | |
| 245 | 0 | 0 |
_aComplete remission of hepatitis B virus-associated nephrotic syndrome from IgA nephropathy following peginterferon therapy. _h[electronic resource] |
| 260 |
_bRenal failure _c2013 |
||
| 300 |
_a295-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBiopsy, Needle |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGlomerulonephritis, IGA _xcomplications |
| 650 | 0 | 4 |
_aHepatitis B virus _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 | _aKidney Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xcomplications |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aViral Load _xdrug effects |
| 700 | 1 | _aPatel, Chinmay | |
| 700 | 1 | _aJhaveri, Kenar D | |
| 773 | 0 |
_tRenal failure _gvol. 35 _gno. 2 _gp. 295-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/0886022X.2012.745785 _zAvailable from publisher's website |
| 999 |
_c22291958 _d22291958 |
||